(Q34667687)

3 August 2017

1 reference

title

Carvedilol: a nonselective beta blocking agent with antioxidant properties (English)

1 reference

3 August 2017

1 reference

Wendy M Book

1

1 reference

3 August 2017

publication date

1 May 2002

1 reference

3 August 2017

published in

Congestive Heart Failure

1 reference

3 August 2017

volume

8

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

173-7, 190

1 reference

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00718.X

The role of oxidative stress in the genesis of heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00718.X

Apoptotic cell death in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00718.X

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00718.X

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00718.X

Effect of beta-blockers on free radical-induced cardiac contractile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00718.X

Normal and abnormal consequences of apoptosis in the human heart. From postnatal morphogenesis to paroxysmal arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00718.X

Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00718.X

Recent observations with beta-adrenoceptor blockade. Beneficial effects in hypertension and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00718.X

Protective effects of carvedilol, a vasodilating beta-adrenoceptor blocker, against in vivo low density lipoprotein oxidation in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00718.X

Reduction of oxidative stress by carvedilol: role in maintenance of ischaemic myocardium viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00718.X

Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2002.00718.X

10.1111/J.1527-5299.2002.00718.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference